Efficacy of Nicotine in Preventing COVID-19
Posted: Sat Jan 23, 2021 7:31 pm
Recently there was referenced in the U.S. National Library of Medicine website: "ClinicalTrial.gov" an ongoing study sponsored by the Assistance Publique - Hôpitaux de Paris about :
Efficacy of Nicotine in Preventing COVID-19 Infection in Caregivers -
Principal Investigator: Zahir AMOURA, MD
If you want to follow the developments on this study you can check this following link from time to time. The study will not wrap up until August 2021, and probably published conclusions from the study will take some time to appear after that.
https://clinicaltrials.gov/ct2/show/NCT04583410
Here is a clip from the Study Description Summary:
Efficacy of Nicotine in Preventing COVID-19 Infection in Caregivers -
Principal Investigator: Zahir AMOURA, MD
If you want to follow the developments on this study you can check this following link from time to time. The study will not wrap up until August 2021, and probably published conclusions from the study will take some time to appear after that.
https://clinicaltrials.gov/ct2/show/NCT04583410
Here is a clip from the Study Description Summary:
The coronavirus disease (COVID-19) epidemic represents a major therapeutic challenge. The highly contagious severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) and the long duration of the disease have led to a massive influx of patients admitted in health services and intensive care units. These patients represent a significant infection risk to the medical staff. According to current knowledge, there are no treatments that prevent the spread of the infection, especially in exposed populations, or the disease progression to a severe form.
Daily active smokers are infrequent among outpatients or hospitalized patients with COVID-19. Several arguments suggest that nicotine is responsible for this protective effect via the nicotinic acetylcholine receptor (nAChR).
Nicotine may inhibit the penetration and spread of the virus and have a prophylactic effect in COVID-19 infection, especially in healthcare workers who are at high risk of infection.